These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Biochemical and immunological status following gene therapy and PEG-ADA therapy for adenosine deaminase (ADA) deficiency. Fairbanks LD, Simmonds HA, Hoogerbrugge PM, van Beusechem VW, Valerio D, Moseley A, Levinsky RJ, Gaspar HB, Morgan G. Adv Exp Med Biol; 1994 Mar 05; 370():391-4. PubMed ID: 7660936 [No Abstract] [Full Text] [Related]
23. In vitro and in vivo studies with human carrier erythrocytes loaded with polyethylene glycol-conjugated and native adenosine deaminase. Bax BE, Bain MD, Fairbanks LD, Webster AD, Chalmers RA. Br J Haematol; 2000 Jun 05; 109(3):549-54. PubMed ID: 10886203 [Abstract] [Full Text] [Related]
24. Reduced thymic output, increased spontaneous apoptosis and oligoclonal B cells in polyethylene glycol-adenosine deaminase-treated patients. Malacarne F, Benicchi T, Notarangelo LD, Mori L, Parolini S, Caimi L, Hershfield M, Notarangelo LD, Imberti L. Eur J Immunol; 2005 Nov 05; 35(11):3376-86. PubMed ID: 16276484 [Abstract] [Full Text] [Related]
25. Antibody responses to bacteriophage phi X174 in patients with adenosine deaminase deficiency. Ochs HD, Buckley RH, Kobayashi RH, Kobayashi AL, Sorensen RU, Douglas SD, Hamilton BL, Hershfield MS. Blood; 1992 Sep 01; 80(5):1163-71. PubMed ID: 1387561 [Abstract] [Full Text] [Related]
26. How We Manage Adenosine Deaminase-Deficient Severe Combined Immune Deficiency (ADA SCID). Kohn DB, Gaspar HB. J Clin Immunol; 2017 May 01; 37(4):351-356. PubMed ID: 28194615 [Abstract] [Full Text] [Related]
28. Bone marrow gene transfer in three patients with adenosine deaminase deficiency. Hoogerbrugge PM, van Beusechem VW, Fischer A, Debree M, le Deist F, Perignon JL, Morgan G, Gaspar B, Fairbanks LD, Skeoch CH, Moseley A, Harvey M, Levinsky RJ, Valerio D. Gene Ther; 1996 Feb 01; 3(2):179-83. PubMed ID: 8867866 [Abstract] [Full Text] [Related]
29. First Occurrence of Plasmablastic Lymphoma in Adenosine Deaminase-Deficient Severe Combined Immunodeficiency Disease Patient and Review of the Literature. Migliavacca M, Assanelli A, Ponzoni M, Pajno R, Barzaghi F, Giglio F, Ferrua F, Frittoli M, Brigida I, Dionisio F, Nicoletti R, Casiraghi M, Roncarolo MG, Doglioni C, Peccatori J, Ciceri F, Cicalese MP, Aiuti A. Front Immunol; 2018 Feb 01; 9():113. PubMed ID: 29456531 [Abstract] [Full Text] [Related]
30. Polyethylene glycol-modified adenosine deaminase improved lung disease but not liver disease in partial adenosine deaminase deficiency. Somech R, Lai YH, Grunebaum E, Le Saux N, Cutz E, Roifman CM. J Allergy Clin Immunol; 2009 Oct 01; 124(4):848-50. PubMed ID: 19665771 [No Abstract] [Full Text] [Related]
31. Insulin-dependent diabetes mellitus and severe atopic dermatitis in a child with adenosine deaminase deficiency. Notarangelo LD, Stoppoloni G, Toraldo R, Mazzolari E, Coletta A, Airò P, Bordignon C, Ugazio AG. Eur J Pediatr; 1992 Nov 01; 151(11):811-4. PubMed ID: 1468454 [Abstract] [Full Text] [Related]
32. Consensus approach for the management of severe combined immune deficiency caused by adenosine deaminase deficiency. Kohn DB, Hershfield MS, Puck JM, Aiuti A, Blincoe A, Gaspar HB, Notarangelo LD, Grunebaum E. J Allergy Clin Immunol; 2019 Mar 01; 143(3):852-863. PubMed ID: 30194989 [Abstract] [Full Text] [Related]
36. A girl with diabetes and severe combined immunodeficiency from adenosine deaminase deficiency. Stoppoloni G, Iafusco D, Amodeo BM, De Felice E, Toraldo R, Betterle C, Notarangelo LD, Tosi G, Accolla RS, Prisco F. J Pediatr Endocrinol Metab; 1997 Mar 01; 10(4):425-8. PubMed ID: 9364370 [Abstract] [Full Text] [Related]
37. Heterogeneity of phenotype in two siblings with adenosine deaminase deficiency. Umetsu DT, Schlossman CM, Ochs HD, Hershfield MS. J Allergy Clin Immunol; 1994 Feb 01; 93(2):543-50. PubMed ID: 8120281 [Abstract] [Full Text] [Related]
38. Management options for adenosine deaminase deficiency; proceedings of the EBMT satellite workshop (Hamburg, March 2006). Booth C, Hershfield M, Notarangelo L, Buckley R, Hoenig M, Mahlaoui N, Cavazzana-Calvo M, Aiuti A, Gaspar HB. Clin Immunol; 2007 May 01; 123(2):139-47. PubMed ID: 17300989 [Abstract] [Full Text] [Related]
39. Treatment of patients with severe combined immunodeficiency due to adenosine deaminase (ADA) deficiency by autologous transplantation of genetically modified bone marrow cells. Hoogerbrugge PM, Vossen JM, v Beusechem VW, Valerio D. Hum Gene Ther; 1992 Oct 01; 3(5):553-8. PubMed ID: 1420454 [No Abstract] [Full Text] [Related]
40. The use of enzyme therapy to regulate the metabolic and phenotypic consequences of adenosine deaminase deficiency in mice. Differential impact on pulmonary and immunologic abnormalities. Blackburn MR, Aldrich M, Volmer JB, Chen W, Zhong H, Kelly S, Hershfield MS, Datta SK, Kellems RE. J Biol Chem; 2000 Oct 13; 275(41):32114-21. PubMed ID: 10908569 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]